Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

Form 8.5 (EPT/RI)

29 May 2018 16:38

RNS Number : 5841P
Canaccord Genuity Limited
29 May 2018
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Canaccord Genuity Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Vernalis Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected party to the Offeree

 

(d) Date dealing undertaken:

25 May 2018

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

Ord 1p

 

 

Buy

200

 

7p

 

 

7p

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

Date of disclosure:

29 May 2018

Contact name:

Sam Cooke

Telephone number:

020 7523 4658

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERFMGZKKLVGRZM
Date   Source Headline
16th Mar 20067:02 amRNSPhase IIa Trial of V1003
16th Mar 20067:02 amRNSPreliminary Results
27th Feb 200610:40 amRNSNotice of Results
24th Jan 20067:00 amRNSLaunch of US Sales Force
21st Dec 20052:30 pmRNSDirector/PDMR Shareholding
21st Dec 200511:19 amRNSHolding(s) in Company
20th Dec 20053:38 pmRNSHolding(s) in Company
20th Dec 20057:00 amRNSFrova Safety Study Completed
19th Dec 20057:01 amRNSOncology Collaboration
14th Dec 20058:23 amRNSCompletion - Cita Acquisition
13th Dec 200511:56 amRNSResults of EGM
12th Dec 200511:49 amRNSHolding(s) in Company
24th Nov 20055:00 pmRNSHolding(s) in Company
23rd Nov 20052:27 pmRNSHolding(s) in Company
18th Nov 20057:01 amRNSProposed acquisition of Cita
11th Nov 20054:01 pmRNSHolding(s) in Company
4th Nov 20057:01 amRNSCollaboration with Britannia
4th Nov 20057:01 amRNSVernalis Acquires Apokyn(R)
10th Oct 200512:47 pmRNSHolding(s) in Company
22nd Sep 20057:01 amRNSAppointment of Piper Jaffray
22nd Sep 20057:01 amRNSInterim Results
16th Sep 200512:30 pmRNSHolding(s) in Company
6th Sep 20057:00 amRNSFrovatriptan Phase III
8th Aug 20053:00 pmRNSHolding(s) in Company
27th Jul 20053:35 pmRNSHolding(s) in Company
26th Jul 20057:00 amRNSIonix acquisition completed
6th Jul 20057:00 amRNSAcquisition of Ionix
30th Jun 20055:23 pmRNSHolding(s) in Company
27th Jun 20057:00 amRNSMRM Interim Phase 3 Data
10th Jun 20055:49 pmRNSHolding(s) in Company
7th Jun 20057:00 amRNSVernalis Appoints Head of US
25th May 20053:00 pmRNSResults of the AGM
23rd May 20054:12 pmRNSHolding(s) in Company
26th Apr 20057:00 amRNSAnnual Report and Accounts
22nd Apr 20054:55 pmRNSHolding(s) in Company
13th Apr 20052:30 pmRNSDirector Shareholding
12th Apr 20051:30 pmRNSEndo/Serena launch RALLY
31st Mar 20054:30 pmRNSHolding(s) in Company
31st Mar 20054:30 pmRNSHolding(s) in Company
31st Mar 20057:00 amRNSOncology Research
21st Mar 200510:29 amRNSResult of EGM
24th Feb 20057:04 amRNSPlacing and Open Offer
24th Feb 20057:04 amRNSCo-promotion of Frova
24th Feb 20057:03 amRNSPreliminary Announcement
14th Feb 20054:58 pmRNSHolding(s) in Company
19th Jan 20057:00 amRNSStarts Clinical Trials

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.